ImageneBio(IMA)
$3.81-0.16 (-7.19%)
IMA
ImageneBio financials statements
$3.81
At close:-0.16 (-7.19%)
Want to see IMA full AI Analyst Report?
ImageneBio (IMA) Ratios
116 Followers
ImageneBio Ratios
IMA's free cash flow for Q3 2026 was $-9.52M. For the 2026 fiscal year, IMA's free cash flow was increased by $0.00 and operating cash flow was $-9.52M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 12.49 | 11.80 | 12.58 | 7.44 | 8.70 |
| Quick Ratio | 12.49 | 11.80 | 12.58 | 7.44 | 8.70 |
| Cash Ratio | 3.11 | 3.65 | 8.44 | 2.79 | 8.54 |
| Solvency Ratio | -2.23 | -2.25 | -3.01 | -2.69 | -0.84 |
| Operating Cash Flow Ratio | -4.26 | -4.27 | -5.61 | -3.45 | -2.22 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 120.45M | $ 111.59M | $ 156.33M | $ 134.72M | $ 196.51M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.05 | 0.06 | 0.03 | 0.03 |
| Debt-to-Equity Ratio | 0.08 | 0.06 | 0.06 | 0.04 | 0.03 |
| Debt-to-Capital Ratio | 0.07 | 0.06 | 0.06 | 0.04 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.15 | 1.12 | 1.13 | 1.17 | 1.19 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.84 | 0.16 | 0.26 | 0.16 | 0.19 |
| Net Debt to EBITDA | 0.56 | 0.91 | 1.47 | 0.77 | 6.70 |
| Profitability Margins | |||||
| Gross Profit Margin | -29.13% | 100.00% | 88.86% | -311.84% | -52.03% |
| EBIT Margin | -5712.38% | -1044.43% | -823.33% | -453.99% | -110.18% |
| EBITDA Margin | -5583.25% | -1000.83% | -812.19% | -449.18% | -108.42% |
| Operating Profit Margin | -6056.38% | -1057.14% | -823.33% | -453.99% | -110.18% |
| Pretax Profit Margin | -5712.38% | -1044.43% | -745.94% | -440.29% | -110.10% |
| Net Profit Margin | -5668.63% | -1044.80% | -744.17% | -440.29% | -110.10% |
| Continuous Operations Profit Margin | -5668.63% | -1044.80% | -744.17% | -440.29% | -110.10% |
| Net Income Per EBT | 99.23% | 100.04% | 99.76% | 100.00% | 100.00% |
| EBT Per EBIT | 94.32% | 98.80% | 90.60% | 96.98% | 99.93% |
| Return on Assets (ROA) | -29.64% | -25.84% | -35.49% | -39.92% | -13.76% |
| Return on Equity (ROE) | -34.06% | -29.04% | -40.16% | -46.79% | -16.41% |
| Return on Capital Employed (ROCE) | -34.18% | -28.30% | -42.40% | -47.03% | -15.47% |
| Return on Invested Capital (ROIC) | -33.39% | -27.51% | -41.47% | -46.44% | -15.34% |
| Return on Tangible Assets | -29.64% | -25.84% | -35.49% | -39.92% | -13.76% |
| Earnings Yield | -120.98% | -3.85% | -6.91% | -5.95% | -0.63% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.62 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.72 | 1.70 | 0.49 | 30.73 | 19.76 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 1.01 | 0.83 | 1.14 | 1.85 | 3.45 |
| Asset Turnover | 0.01 | 0.02 | 0.05 | 0.09 | 0.13 |
| Working Capital Turnover Ratio | 0.01 | 0.02 | 0.06 | 0.09 | 0.18 |
| Cash Conversion Cycle | 82.84 | -214.55 | -739.30 | -11.88 | -18.47 |
| Days of Sales Outstanding | 591.30 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 508.46 | 214.55 | 739.30 | 11.88 | 18.47 |
| Operating Cycle | 591.30 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -8.81 | -0.95 | -1.91 | -2.05 | -1.67 |
| Free Cash Flow Per Share | -8.81 | -0.95 | -1.92 | -2.09 | -1.72 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -192.62 | -51.79 | -34.23 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -192.62 | -51.79 | -34.23 |
| Operating Cash Flow Coverage Ratio | -4.79 | -6.12 | -7.43 | -13.02 | -8.62 |
| Operating Cash Flow to Sales Ratio | -59.80 | -13.14 | -8.71 | -4.75 | -1.94 |
| Free Cash Flow Yield | -127.64% | -4.84% | -8.12% | -6.54% | -1.15% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.72 | -19.29 | -14.47 | -16.80 | -158.68 |
| Price-to-Sales (P/S) Ratio | 46.85 | 271.35 | 107.71 | 73.96 | 174.71 |
| Price-to-Book (P/B) Ratio | 0.28 | 7.54 | 5.81 | 7.86 | 26.04 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.78 | -20.64 | -12.31 | -15.29 | -87.30 |
| Price-to-Operating Cash Flow Ratio | -0.78 | -20.64 | -12.37 | -15.59 | -89.85 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.52 | 1.02 | -0.17 | 2.27 |
| Enterprise Value Multiple | -0.28 | -26.20 | -11.79 | -15.69 | -154.44 |
| Enterprise Value | 12.51M | 917.85M | 877.46M | 1.10B | 5.19B |
| EV to EBITDA | -0.28 | -26.20 | -11.79 | -15.69 | -154.44 |
| EV to Sales | 15.64 | 262.24 | 95.79 | 70.49 | 167.45 |
| EV to Free Cash Flow | -0.26 | -19.95 | -10.95 | -14.57 | -83.67 |
| EV to Operating Cash Flow | -0.26 | -19.95 | -11.00 | -14.86 | -86.11 |
| Tangible Book Value Per Share | 24.51 | 2.61 | 4.07 | 4.06 | 5.78 |
| Shareholders’ Equity Per Share | 24.51 | 2.61 | 4.07 | 4.06 | 5.78 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | -0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.15 | 0.07 | 0.22 | 0.43 | 0.86 |
| Net Income Per Share | -8.35 | -0.76 | -1.63 | -1.90 | -0.95 |
| Tax Burden | 0.99 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.91 | 0.97 | 1.00 |
| Research & Development to Revenue | 35.66 | 9.17 | 6.51 | 4.12 | 1.52 |
| SG&A to Revenue | 25.91 | 2.40 | 2.72 | 1.42 | 0.58 |
| Stock-Based Compensation to Revenue | 19.24 | 1.51 | 0.00 | 0.48 | 0.17 |
| Income Quality | 0.91 | 0.93 | 1.17 | 1.08 | 1.77 |
Currency in USD
